All In MedTech

FDA Clearance Tracker · P130024-S009

LUTONIX 035 DRUG COATED BALLOON PTA CATHETER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 7, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 7, 2017

Approved

Time to decision

400 days

Received Jan 4, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P130024-S009
Device name
LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Applicant
Lutonix
Applicant location
New Hope, MN
Received
Jan 4, 2016
Decided
Feb 7, 2017
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P130024

Device type

Device class
Class III

Every decision under product code ONU

FDA's approval statement

As written in FDA's record.

Approval for Lutonix DCB is indicated for percutaneous transluminal angioplasty, after appropriate vessel preparation, of de novo, restenotic, or in-stent restenotic lesions up to 300 mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4-7 mm.

Source documents

Other decisions for Lutonix

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.